When cybrids from either group were treated with the anti-VEGF compounds bevacizumab (Avastin®), ranibizumab (Lucentis®), or aflibercept (Eylea®), phagocytic function was decreased, with similar fold-changes in function between AMD and normal cybrids38. This evidence concerns the gene VEGFA and age-related macular degeneration.